CN106581225A - Erysipelas powder - Google Patents

Erysipelas powder Download PDF

Info

Publication number
CN106581225A
CN106581225A CN201611158990.7A CN201611158990A CN106581225A CN 106581225 A CN106581225 A CN 106581225A CN 201611158990 A CN201611158990 A CN 201611158990A CN 106581225 A CN106581225 A CN 106581225A
Authority
CN
China
Prior art keywords
radix
erysipelas
medicine
fresh
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611158990.7A
Other languages
Chinese (zh)
Inventor
于明儒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201611158990.7A priority Critical patent/CN106581225A/en
Publication of CN106581225A publication Critical patent/CN106581225A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • A61K36/744Gardenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125Camphor; Nuclear substituted derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/324Boswellia, e.g. frankincense
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/328Commiphora, e.g. mecca myrrh or balm of Gilead
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/33Cactaceae (Cactus family), e.g. pricklypear or Cereus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634Forsythia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses erysipelas powder. The erysipelas powder is characterized by being prepared from the following ingredients in parts by weight: 450-550g of fresh cactus, 95-105g of unprocessed rhubarb, 25-35g of unprocessed frankincense, 25-35g of unprocessed myrrh, 25-35g of cape jasmine fruits, 25-35g of forsythia fruits, 25-35g of dahurian angelica roots, 4-6g of borneol and 4-6g of camphor. The powder is in clinical application for over 5 years and cures over 500 patients, the cured patients are paid a return visit for a long time, and people find that after erysipelas patients are subjected to external application by the erysipelas powder, the symptoms of the patients are obviously relieved after the powder is used for multiple times, and the erysipelas powder has a better curative effect in combination with assistance of drugs.

Description

Erysipelas dissipates
Technical field
The present invention relates to technical field of Chinese medicine, and in particular to a kind of wind and heat dispersing, the external application type erysipelas of subduing swelling and detoxicating dissipates.
Background technology
Erysipelas is that skin is rubescent suddenly, a kind of color such as acute illness of red fat liquoring dye, dry also known as pellet.According to its site of pathological change With the difference of clinical manifestation, there are different titles in TCM Document:Head, face person are betided, claims erysipelas on the head;Under betiding the side of body Waist crotch person, claims erysipelas in the lower part of the trunk;The person that betides lower limb, claims erysipelass or lower limb urticaria;Neonate erysipelas, skin lesion appearing without definite location claims red wandering erysipelases.
Primary disease doctor trained in Western medicine is also referred to as erysipelas;It is by the microbial skin of A races Type B hammer and a kind of hypodermic acute inflammation Disease, often shows as boundary clearly limitation red and swollen heat pain, is apt to occur in face and lower limb, can there is the General Symptomies such as headache, heating. Infringement also can spread (erysipelas ambulans) to elsewhere or repeatedly occur (recurrent erysipelas) at primary lesion position.Multiple relapse person Claim chronic recurrent erysipelas, local often secondary lymphedema.Any position can be betided, with shank, face, forearm, handss Foot and baby's abdominal part are common.Other positions also can occur.Regional glandular enlargement.Whole year can fall ill, but be common in spring, autumn two Season.Erythra is the erythema of slightly above skin surface, lifts hot swelling, and color such as applies pellet, and the colour fading of pressure restores to the original state after letting go, table Face anxiety is shinny, normal rapid to surrounding extension with normal skin boundary clear.Severe patient erythema surface can occur vesicle or big Bleb, more severe patient can develop into gangrene.If pyretic toxicity caves in, agitation, coma, delirium, deep red tongue, yellow fur or yellow rough, arteries and veins are seen Big vast number etc. is demonstrate,proved.The course of disease is acute process.
Recurrent exerbation person is referred to as chronic recurrent erysipelas;With the passing of time can secondary formation elephatiasis (common with shank).Primary disease master Want Therapeutic Method to be clearing away heat,cooling blood and removing toxin, and preferably combine external treatment.The determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs wind heat fire-toxin type of erysipelas.
The content of the invention
The technical problem to be solved is to provide a kind of cure rate height, and drug safety reliability, medication is convenient Erysipelas dissipates.
The technical problem to be solved employs the following technical solutions to realize:
A kind of erysipelas dissipates, and is made up of the component of following weight:Fresh Radix et Caulis Opuntiae Dillenii 450-550g, Radix Et Rhizoma Rhei 95-105g, Olibanum 25-35g, Myrrha 25-35g, Fructus Gardeniae 25-35g, Fructus Forsythiae 25-35g, Radix Angelicae Dahuricae 25-35g, Borneolum Syntheticum 4-6g and Camphora 4-6g;
The preferable weight of each component is:Fresh Radix et Caulis Opuntiae Dillenii 500g, Radix Et Rhizoma Rhei 100g, Olibanum 30g, Myrrha 30g, Fructus Gardeniae 30g, Fructus Forsythiae 30g, Radix Angelicae Dahuricae 30g, Borneolum Syntheticum 5g and Camphora 5g;
The preferable weight of each component is:Fresh Radix et Caulis Opuntiae Dillenii 450g, Radix Et Rhizoma Rhei 95g, Olibanum 25g, Myrrha 25g, Fructus Gardeniae 25g, Fructus Forsythiae 25g, Radix Angelicae Dahuricae 25g, Borneolum Syntheticum 4g and Camphora 4g;
The preferable weight of each component is:Fresh Radix et Caulis Opuntiae Dillenii 550g, Radix Et Rhizoma Rhei 105g, Olibanum 35g, Myrrha 35g, Fructus Gardeniae 35g, Fructus Forsythiae 35g, Radix Angelicae Dahuricae 35g, Borneolum Syntheticum 6g and Camphora 6g;
The preferable weight of each component is:Fresh Radix et Caulis Opuntiae Dillenii 550g, Radix Et Rhizoma Rhei 95g, Olibanum 35g, Myrrha 25g, Fructus Gardeniae 35g, Fructus Forsythiae 25g, Radix Angelicae Dahuricae 35g, Borneolum Syntheticum 4g and Camphora 6g;
The preferable weight of each component is:Fresh Radix et Caulis Opuntiae Dillenii 450g, Radix Et Rhizoma Rhei 105g, Olibanum 25g, Myrrha 35g, Fructus Gardeniae 25g, Fructus Forsythiae 35g, Radix Angelicae Dahuricae 25g, Borneolum Syntheticum 6g and Camphora 4g;
The scattered manufacture method of above-mentioned erysipelas and usage:
(1) fresh Radix et Caulis Opuntiae Dillenii is cleaned, goes prickle to smash to pieces for mud using fresh herb;
(2) each medicine is smashed as end by above-mentioned dosage;
(3) said medicine is tuned into into medicine puree, spreads on affected part, external preservative film parcel, indwelling 6 hours.
Dosage form:External application dissipates
Function:Wind and heat dispersing, subduing swelling and detoxicating
Cure mainly:Erysipelas (wind heat fire-toxin type)
Complementary therapy:
1st, needle-knife solution, decompression treatment;
2nd, Western medicine auxiliary treatment;1. whole body therapeutic:Principle is removing risk factor, Cure the Primary Disease stove.2. antibiosis Extract for treating:First-selected penicillin, can vein or intramuscular injection.
3rd, tobacco and wine, polydipsia boiled water are avoided.
Pharmaceutical analysiss:
Radix et Caulis Opuntiae Dillenii:
【The property of medicine】It is sweet, it is mild-natured.Attach to the lung and stomach meridians.
【Effect】Promoting flow of QI and blood, heat-clearing and toxic substances removing.
【Pharmacological action】Reducing swelling and alleviating pain, promoting flow of QI and blood, damp eliminating is brought down a fever, granulation promoting.
Radix Et Rhizoma Rhei:
【The property of medicine】Hardship, trembles with fear.Returns spleen, stomach, large intestine, liver, heart channel.
【Effect】Heat and toxic materials clearing away, clearing away heat-fire, hemostasis, removing toxic substances, blood circulation promoting and blood stasis dispelling.
【Pharmacological action】Radix Et Rhizoma Rhei has very strong anti-infectious function, defying age antioxidation, can adjust immunity, resist The effects such as inflammation, refrigeration function, resisting pathogenic microbes effect, purging heat and dredging bowels, removing pathogenic heat from blood and toxic substance from the body, eliminating blood stasis and inducing menstruation.
Olibanum:
【The property of medicine】Acrid, bitter, warm.Return liver, the heart, spleen channel.
【Effect】Blood-activating and qi-promoting pain relieving, detumescence and promoting granulation.
【Pharmacological action】This medicine can promoting blood circulation, removing blood stasis and relieving pain, and can promoting blood circulation and detumescence, removing the necrotic tissue and promoting granulation;Pungent scattered temperature is led to, and can be invigorated blood circulation Promoting the circulation of QI to relieve pain, but can blood stasis dispelling stretch muscle and exempt from numbness.
Myrrha:
【The property of medicine】It is bitter, pungent, flat.GUIXIN liver spleen channel.
【Effect】Promoting blood circulation and stopping pain, detumescence and promoting granulation.
【Pharmacological action】This medicine cures mainly similar to Olibanum.Control that the traumatic injury stasis of blood is stagnant to swell and ache, surgery ulcer sore pain, after skin infection is burst Do not close up and all pains of the stagnant trusted subordinate of all stasis of bloods long, be often use with Olibanum mutual reinforcement between;Myrrha relatively dissipates blood blood stasis dispelling.
Fructus Gardeniae:
【The property of medicine】Hardship, trembles with fear.GUIXIN, lung, tri-jiao channel.
【Effect】Purging intense heat relieving restlessness, clearing away heat-damp and promoting diuresis, removing toxic substances and promoting subsidence of swelling;Fructus Gardeniae Preparatuss:Cooling blood for hemostasis.
【Pharmacological action】This medicine is mainly used in Vexed, dry disturbs not peaceful key medicine;It is clearing away heat-damp and promoting diuresis for jaundice due to damp-heat The key medicine of jaundice eliminating;For conjunctival congestion and swelling pain, sore swollen toxin, traumatic injury, three burnt pathogenic heats, removing pathogenic heat from blood and toxic substance from the body, reducing swelling and alleviating pain can be clearly rushed down;With In heat in blood bleeding, and pathogenic fire purging and cooling blood for hemostasis.
Fructus Forsythiae:
【The property of medicine】Hardship, is slightly cold.Return lung, the heart, small intestine meridian.
【Effect】Heat-clearing and toxic substances removing, carbuncle that disappears dissipating bind, dispelling wind and heat pathogens.
【Pharmacological action】This medicine is used for carbuncle sore tumefacting virus, scrofula subcutaneous nodule, affection due to external wind and heat, warm disease heating;This medicine can also clear away heart-fire profit Urine, with controlling puckery pain of heat gonorrhea.
The Radix Angelicae Dahuricae:
【The property of medicine】It is pungent, temperature.Return stomach, large intestine, lung meridian.
【Effect】Expelling wind and cold, sensible pain relieving, eliminating dampness stops band, detumescence and apocenosis.
【Pharmacological action】Reach on this medicine fragrance, enter lung and it is main enter positive bright stomach, be both apt to scattered Yangming Channel wind-cold damp pathogen, be apt to again logical Key pain relieving, the product conventional to control wind and cold table disease, headache, toothache, nasal obstruction, nasal sinusitis etc.;Can also eliminating dampness stops band, antipruritic, detumescence and apocenosis, Control the card such as leukorrhagia, skin pruritus and sore swollen toxin.
Borneolum Syntheticum:
【The property of medicine】Pungent, hardship, is slightly cold.GUIXIN, spleen, lung meridian.
【Effect】Inducing resuscitation of having one's ideas straightened out, clearing away heat to alleviate pain.
【Pharmacological action】For sore swell and ache curative, do not hold back after bursting, energy heat-clearing and toxic substances removing, erosion prevention and muscle growing;Topical application have pain relieving and Antisepsises.Resist myocardial ischemia.Higher concentration has to glucose coccus, streptococcus, Diplococcus pneumoniae, escherichia coli and dermatophytess Inhibitory action.
Camphora:
【The property of medicine】It is pungent, heat;It is poisonous.GUIXIN, spleen channel.
【Effect】Having one's ideas straightened out, it is dirty to ward off;External:Dehumidifying parasite killing, warming and odynolysis.
【Pharmacological action】For scabies eczema, prurituss are festered;Tenderness and traumatic injury pain.
Efficacy analysis:
The medicine is cured the example of patient more than 500, and carries out long-term tracking and pay a return visit in clinical practice more than 5 years, finds erysipelas Patient dissipates external application with erysipelas, and patient's symptom is relieved after medication for several times, and with composite medicine auxiliary, curative effect is more preferably.
The invention has the beneficial effects as follows:The present invention adopts Chinese herbal medicine formula, material to be easy to get, and preparation method is simple, controls curative effect Really good, price is low, instant effect, curative effect reliability, with system with without obvious adverse reaction and side effect.
Specific embodiment
In order that technological means, creation characteristic, reached purpose and effect that the present invention is realized are easy to understand, tie below Specific embodiment is closed, the present invention is expanded on further.
Embodiment 1
A kind of erysipelas dissipates, and is made up of the component of following weight:Fresh Radix et Caulis Opuntiae Dillenii 500g, Radix Et Rhizoma Rhei 100g, Olibanum 30g, life Myrrha 30g, Fructus Gardeniae 30g, Fructus Forsythiae 30g, Radix Angelicae Dahuricae 30g, Borneolum Syntheticum 5g and Camphora 5g;
The scattered manufacture method of above-mentioned erysipelas and usage:
(1) fresh Radix et Caulis Opuntiae Dillenii is cleaned, goes prickle to smash to pieces for mud using fresh herb;
(2) each medicine is smashed as end by above-mentioned dosage;
(3) said medicine is tuned into into medicine puree, spreads on affected part, external preservative film parcel, indwelling 6 hours.
Embodiment 2
A kind of erysipelas dissipates, and is made up of the component of following weight:Fresh Radix et Caulis Opuntiae Dillenii 450g, Radix Et Rhizoma Rhei 95g, Olibanum 25g, life do not have Medicine 25g, Fructus Gardeniae 25g, Fructus Forsythiae 25g, Radix Angelicae Dahuricae 25g, Borneolum Syntheticum 4g and Camphora 4g;
The scattered manufacture method of above-mentioned erysipelas and usage:
(1) fresh Radix et Caulis Opuntiae Dillenii is cleaned, goes prickle to smash to pieces for mud using fresh herb;
(2) each medicine is smashed as end by above-mentioned dosage;
(3) said medicine is tuned into into medicine puree, spreads on affected part, external preservative film parcel, indwelling 6 hours.
Embodiment 3
A kind of erysipelas dissipates, and is made up of the component of following weight:Fresh Radix et Caulis Opuntiae Dillenii 550g, Radix Et Rhizoma Rhei 105g, Olibanum 35g, life Myrrha 35g, Fructus Gardeniae 35g, Fructus Forsythiae 35g, Radix Angelicae Dahuricae 35g, Borneolum Syntheticum 6g and Camphora 6g;
The scattered manufacture method of above-mentioned erysipelas and usage:
(1) fresh Radix et Caulis Opuntiae Dillenii is cleaned, goes prickle to smash to pieces for mud using fresh herb;
(2) each medicine is smashed as end by above-mentioned dosage;
(3) said medicine is tuned into into medicine puree, spreads on affected part, external preservative film parcel, indwelling 6 hours.
Embodiment 4
A kind of erysipelas dissipates, and is made up of the component of following weight:Fresh Radix et Caulis Opuntiae Dillenii 550g, Radix Et Rhizoma Rhei 95g, Olibanum 35g, life do not have Medicine 25g, Fructus Gardeniae 35g, Fructus Forsythiae 25g, Radix Angelicae Dahuricae 35g, Borneolum Syntheticum 4g and Camphora 6g;
The scattered manufacture method of above-mentioned erysipelas and usage:
(1) fresh Radix et Caulis Opuntiae Dillenii is cleaned, goes prickle to smash to pieces for mud using fresh herb;
(2) each medicine is smashed as end by above-mentioned dosage;
(3) said medicine is tuned into into medicine puree, spreads on affected part, external preservative film parcel, indwelling 6 hours.
Embodiment 5
A kind of erysipelas dissipates, and is made up of the component of following weight:Fresh Radix et Caulis Opuntiae Dillenii 450g, Radix Et Rhizoma Rhei 105g, Olibanum 25g, life Myrrha 35g, Fructus Gardeniae 25g, Fructus Forsythiae 35g, Radix Angelicae Dahuricae 25g, Borneolum Syntheticum 6g and Camphora 4g;
The scattered manufacture method of above-mentioned erysipelas and usage:
(1) fresh Radix et Caulis Opuntiae Dillenii is cleaned, goes prickle to smash to pieces for mud using fresh herb;
(2) each medicine is smashed as end by above-mentioned dosage;
(3) said medicine is tuned into into medicine puree, spreads on affected part, external preservative film parcel, indwelling 6 hours.
Medical record case (originate by case:Jieshou City pain disease institute)
1st, patient, Wang, man, 46 years old.Because of " right lower extremity swells and ache 10 days, generates heat 4 days ".Patient occurred suddenly right before 10 days Lower limb external malleolus red rash, spreads immediately to surrounding, and pain is obvious, at that time without heating.In local clinic infusion treatment for several times, swell Pain is gradually deducted, but red rash increases.Anti-inflammatory treatment is given, heating occurs, up to 41 degree, patient's private prosecution effect is failed to understand It is aobvious;The diagnosis and treatment of Sui Lai our hospital, outpatient service with:" erysipelas " income institute further treats;Human health screening:T:39.5 degree, P:116 beats/min, R: 20 beats/min, BP130/80mmHg.Pharyngeal mild hyperaemia, tonsil has no enlargement.Heart and lung auscultation no abnormality seen.Abdomen is soft, without pressure Bitterly, rebound tenderness, does not touch under liver spleen costal margin, and Shuan Shen areas are without percussion pain, and borborygmus are normal.Right lower extremity external malleolus is shown in a diameter about 8cm Kermesinus erythra, clear border, tenderness, local skin temperature rise.Visible multiple kermesinus erythra that differ in size before right lower extremity shin.
Give erysipelas to dissipate external application during in hospital, and coordinate local pin lancination blood treatment;Doctor's advice gives antiinflammatory, promoting blood circulation, blood stasis dispelling etc. Supporting Therapy, and cooperation to the ill lies up, drinks more water.
In hospital 10 days right lower extremity external malleolus red rash disappear, and local skin Wen Bugao, without red and swollen heat pain, gives and leaves hospital.
2nd, patient, Lee so-and-so, man, 56 years old.Because " heating with right lower extremity skin it is red, pain 2 days ".Patient went out suddenly before 2 days Existing right lower extremity swelling, pain is hard and have tenderness substantially, and heating, rubescent occurs in suffering limb, and systemic pain is uncomfortable, fear of cold, heating, The symptoms such as headache, weak and inappetence.38.5 degree of body temperature, 88 beats/min of pulse, blood pressure 130/80mmhg, spirit are surveyed when being admitted to hospital It is not good enough, to swallow without redness, tonsil is without enlargement;Double pulmonary respiration sounds are clear, do not hear and rale;Right lower extremity is red and swollen, and Pi Wen is slightly higher compared with offside. Blood WBC:16.2*109, it is neutral:82%;Patient diagnosis:" erysipelas " admits to hospital.
Erysipelas for several times is given during in hospital and dissipates external application, administer locally to the treatment of pin lancination blood, medicine gives penicillin 6,400,000, 2 times a day, intravenous infusion.
Body temperature has recovered normal after treating three days, and congestion and swelling pain is slightly;Treatment 5 days is continued to strengthen, after symptom disappears substantially Discharge.
The ultimate principle and principal character and advantages of the present invention of the present invention has been shown and described above.The technology of the industry Personnel it should be appreciated that the present invention is not restricted to the described embodiments, the simply explanation described in above-described embodiment and description this The principle of invention, without departing from the spirit and scope of the present invention, the present invention also has various changes and modifications, these changes Change and improvement is both fallen within scope of the claimed invention.The claimed scope of the invention by appending claims and its Equivalent thereof.

Claims (7)

1. a kind of erysipelas dissipates, it is characterised in that be made up of the component of following weight:Fresh Radix et Caulis Opuntiae Dillenii 450-550g, Radix Et Rhizoma Rhei 95- 105g, Olibanum 25-35g, Myrrha 25-35g, Fructus Gardeniae 25-35g, Fructus Forsythiae 25-35g, Radix Angelicae Dahuricae 25-35g, Borneolum Syntheticum 4-6g and Camphor tree Brain 4-6g.
2. erysipelas according to claim 1 dissipates, it is characterised in that be made up of the component of following weight:Fresh Radix et Caulis Opuntiae Dillenii 500g, Radix Et Rhizoma Rhei 100g, Olibanum 30g, Myrrha 30g, Fructus Gardeniae 30g, Fructus Forsythiae 30g, Radix Angelicae Dahuricae 30g, Borneolum Syntheticum 5g and Camphora 5g.
3. erysipelas according to claim 1 dissipates, it is characterised in that be made up of the component of following weight:Fresh Radix et Caulis Opuntiae Dillenii 450g, Radix Et Rhizoma Rhei 95g, Olibanum 25g, Myrrha 25g, Fructus Gardeniae 25g, Fructus Forsythiae 25g, Radix Angelicae Dahuricae 25g, Borneolum Syntheticum 4g and Camphora 4g.
4. erysipelas according to claim 1 dissipates, it is characterised in that be made up of the component of following weight:Fresh Radix et Caulis Opuntiae Dillenii 550g, Radix Et Rhizoma Rhei 105g, Olibanum 35g, Myrrha 35g, Fructus Gardeniae 35g, Fructus Forsythiae 35g, Radix Angelicae Dahuricae 35g, Borneolum Syntheticum 6g and Camphora 6g.
5. erysipelas according to claim 1 dissipates, it is characterised in that be made up of the component of following weight:Fresh Radix et Caulis Opuntiae Dillenii 550g, Radix Et Rhizoma Rhei 95g, Olibanum 35g, Myrrha 25g, Fructus Gardeniae 35g, Fructus Forsythiae 25g, Radix Angelicae Dahuricae 35g, Borneolum Syntheticum 4g and Camphora 6g.
6. erysipelas according to claim 1 dissipates, it is characterised in that be made up of the component of following weight:Fresh Radix et Caulis Opuntiae Dillenii 450g, Radix Et Rhizoma Rhei 105g, Olibanum 25g, Myrrha 35g, Fructus Gardeniae 25g, Fructus Forsythiae 35g, Radix Angelicae Dahuricae 25g, Borneolum Syntheticum 6g and Camphora 4g.
7. it is a kind of to prepare the scattered method of erysipelas described in claim 1, it is characterised in that step is as follows:
(1) fresh Radix et Caulis Opuntiae Dillenii is cleaned, goes prickle to smash to pieces for mud using fresh herb;
(2) each medicine is smashed as end by above-mentioned dosage;
(3) said medicine is tuned into into medicine puree, spreads on affected part, external preservative film parcel, indwelling 6 hours.
CN201611158990.7A 2016-12-15 2016-12-15 Erysipelas powder Pending CN106581225A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611158990.7A CN106581225A (en) 2016-12-15 2016-12-15 Erysipelas powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611158990.7A CN106581225A (en) 2016-12-15 2016-12-15 Erysipelas powder

Publications (1)

Publication Number Publication Date
CN106581225A true CN106581225A (en) 2017-04-26

Family

ID=58802860

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611158990.7A Pending CN106581225A (en) 2016-12-15 2016-12-15 Erysipelas powder

Country Status (1)

Country Link
CN (1) CN106581225A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107137468A (en) * 2017-05-28 2017-09-08 刘秀霞 External application type erysipelas controls agent

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102626454A (en) * 2012-05-10 2012-08-08 蔡立 Traditional Chinese medicine combination for treating erysipelas
CN104491328A (en) * 2014-12-10 2015-04-08 马建国 Ointment for treating crural erysipelas and preparation method for ointment
CN105412692A (en) * 2015-11-26 2016-03-23 于明儒 Traditional Chinese medicine preparation for treating arthroncus of knees

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102626454A (en) * 2012-05-10 2012-08-08 蔡立 Traditional Chinese medicine combination for treating erysipelas
CN104491328A (en) * 2014-12-10 2015-04-08 马建国 Ointment for treating crural erysipelas and preparation method for ointment
CN105412692A (en) * 2015-11-26 2016-03-23 于明儒 Traditional Chinese medicine preparation for treating arthroncus of knees

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107137468A (en) * 2017-05-28 2017-09-08 刘秀霞 External application type erysipelas controls agent

Similar Documents

Publication Publication Date Title
CN104258278B (en) Gushangling (for bone injury) spray
CN102641438B (en) Preparation method for traditional Chinese medicine for treating heat-toxin ecthyma
CN104398997B (en) It is a kind of for Chinese medicine composition of scleroderma circumscriptum and preparation method thereof
CN109331130A (en) The traditional Chinese medicine for outer use for treating hemorrhoid
CN104689132A (en) Traditional Chinese medicine composition for treating psoriasis
CN106581225A (en) Erysipelas powder
CN101249200B (en) Chinese medicine lotion preparation for curing shallow wounds
CN103908600A (en) Externally-applied medicine for treating rheumatoid arthritis damp-heat blockage symptom as well as preparation method and administration method thereof
CN106421702A (en) Traditional Chinese medicine composite for treating coronary heart disease
CN102614479B (en) Traditional Chinese medicine lotion preparation method for curing kidney-yang deficiency ecthyma
CN104800302A (en) Externally applied plaster for treating thromboangiitis obliterans and preparation method
CN108653562A (en) Treat the Chinese medicine of burn and scald
CN109010779A (en) A kind of traditional Chinese medicine lotion and its application method for treating hemorrhoid
CN103656100B (en) A kind of Chinese herbal medicine treating myocardial ischemia
CN102526382A (en) Plaster for relieving swelling and pain
CN102861195B (en) Drug composition for treating rheumatism pain
CN106474236A (en) A kind of treat pharmaceutical composition of pruitus and preparation method thereof
CN105362944A (en) Traditional Chinese medicine ointment for treating orthopedics sprain and contusion
CN105920233A (en) Home-made lotion for warm-water hip bath after operation of mixed hemorrhoids
CN105055596B (en) A kind of treat chronic osteomyelitis and battalion's antiphlogistic bolus and preparation method thereof
CN102526687B (en) Preparation method of Chinese medicinal lotion for treating wearing deficient ecthyma
CN104689254A (en) Traditional Chinese medicine composition for treating psoriasis
CN104398910A (en) Traditional Chinese medicine preparation for treating synovitis
CN102614437B (en) Preparation method of traditional Chinese medicine lotion for treating non-healing type ecthyma
CN104721439A (en) Blood stasis eliminating and blood circulation promoting traditional Chinese medicine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170426